tailieunhanh - From Molecules To Minds

On June 25, 2008, more than 70 of the leading neuroscientists in the world gathered at the National Academy of Sciences building in Wash- ington, DC, for a workshop hosted by the Institute of Medicine’s (IOM’s) Forum on Neuroscience and Nervous System Disorders titled, “From Molecules to Mind: Challenges for the 21st Century.” Their goals were significant: Each participant was asked to identify one or two “Grand Challenges” that could galvanize both the scientific community and the public around the possibilities for neuroscience in the 21st cen- tury. . | í FROM MOLECULES TO MINDS Challenges for the 21st Century WORKSHOP SUMMARY Matthew Hougan and Bruce Altevogt Rapporteurs Forum on Neuroscience and Nervous System Disorders Board on Health Sciences Policy INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES THE NATIONAL ACADEMIES PRESS Washington . THE NATIONAL ACADEMIES PRESS 500 Fifth Street . Washington DC 20001 NOTICE The project that is the subject of this report was approved by the Governing Board of the National Research Council whose members are drawn from the councils of the National Academy of Sciences the National Academy of Engineering and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by contracts between the National Academy of Sciences and the Alzheimer s Association AstraZeneca Pharmaceuticals Inc. CeNeRx Biopharma the Department of Health and Human Services National Institutes of Health NIH Contract No. N01-OD-4-213 through the National Eye Institute the National Institute of Mental Health the National Institute of Neurological Disorders and Stroke the National Institute on Aging the National Institute on Alcohol Abuse and Alcoholism the National Institute on Drug Abuse and the NIH Blueprint for Neuroscience Research Eli Lilly and Company GE Healthcare Inc. GlaxoSmithKline Inc. Johnson Johnson Pharmaceutical Research and Development Inc. Merck Research Laboratories Inc. the National Multiple Sclerosis Society the National Science Foundation Contract No. OIA-0753701 the Society for Neuroscience and Wyeth Research Inc. The views presented in this publication are those of the editors and attributing authors and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13 978-0-309-12092-0 International Standard Book Number-10 0-309-12092-6 Additional copies of .

• Y khoa - Dược
• Temporal Resolution
• Neural Networks
• Environment Interactions
• Brain Plasticity
• Way Forward
• Clinical Importance